<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04100031</url>
  </required_header>
  <id_info>
    <org_study_id>xuwen2018-082</org_study_id>
    <nct_id>NCT04100031</nct_id>
  </id_info>
  <brief_title>Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract Surgery</brief_title>
  <official_title>Efficacy of an Ocular Bandage Contact Lens for the Treatment of Dry Eye After Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the efficacy of an ocular bandage contact lens for the treatment of dry eye after
      cataract surgery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">June 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Ocular Surface Disease Index at 1 week</measure>
    <time_frame>0 day, 1 week postoperative</time_frame>
    <description>Ocular Surface Disease Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Ocular Surface Disease Index at 1 month</measure>
    <time_frame>0 day, 1 month postoperative</time_frame>
    <description>Ocular Surface Disease Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline meibography score at 1 week</measure>
    <time_frame>0 day, 1 week postoperative</time_frame>
    <description>meibography score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline meibography score at 1 month</measure>
    <time_frame>0 day, 1 month postoperative</time_frame>
    <description>meibography score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline of non-invasive keratograph tear meniscus height at 1 month</measure>
    <time_frame>0 day, 1 month postoperative</time_frame>
    <description>non-invasive keratograph tear meniscus height</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline of non-invasive keratograph tear meniscus height at 1 week</measure>
    <time_frame>0 day, 1 week postoperative</time_frame>
    <description>non-invasive keratograph tear meniscus height</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline noninvasive tear breakup time at 1 week</measure>
    <time_frame>0 day, 1 week postoperative</time_frame>
    <description>noninvasive tear breakup time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline noninvasive tear breakup time at 1 month</measure>
    <time_frame>0 day, 1 month postoperative</time_frame>
    <description>noninvasive tear breakup time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Schirmer I test at 1 week</measure>
    <time_frame>0 day, 1 week postoperative</time_frame>
    <description>Schirmer I test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline Schirmer I test at 1 month</measure>
    <time_frame>0 day, 1 month postoperative</time_frame>
    <description>Schirmer I test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>slit-lamp examination</measure>
    <time_frame>0 day</time_frame>
    <description>slit-lamp examination</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from Baseline IL-1, IL-6, IL-12, IL-10, IL-8, TNF-Î± and ICAM-1 level at 1 month</measure>
    <time_frame>0 day and 1 month postoperative</time_frame>
    <description>cytokine levels</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Cataract</condition>
  <condition>Dry Eye</condition>
  <arm_group>
    <arm_group_label>BCL group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bandage contact lenses</intervention_name>
    <description>wear bandage contact lensesfor a week after cataract surgery.</description>
    <arm_group_label>BCL group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification</intervention_name>
    <description>underwent standard phacoemulsification through a 2.8-mm clear corneal temporal incision and intraocular lens</description>
    <arm_group_label>BCL group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age-related cataract

          2. dry eye disease

        Exclusion Criteria:

          1. a history of surgery and other ocular diseases

          2. contact lens use

          3. ocular therapies such as 0.05% cyclosporine A or steroids in the last 3 months. had
             4.any systemic diseases such as heart diseases, diabetes and psychosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>wen xu, PHD</last_name>
    <phone>+86 571 87783897</phone>
    <email>xuwen2003@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Second Affiliated Hospital, Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>wen Xu, PHD</last_name>
      <phone>+86 571 87783897</phone>
      <email>xuwen2003@zju.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 23, 2019</study_first_posted>
  <last_update_submitted>January 8, 2020</last_update_submitted>
  <last_update_submitted_qc>January 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Capsule Opacification</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

